Comparative Pharmacology
Head-to-head clinical analysis: CYTALUX versus SPY AGENT GREEN KIT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CYTALUX versus SPY AGENT GREEN KIT.
CYTALUX vs SPY AGENT GREEN KIT
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
CYTALUX (pafolacianine) is a folate receptor-targeted optical imaging agent. It binds to folate receptors (FRα) overexpressed on cancer cells and, upon activation by light, produces fluorescence for intraoperative imaging.
SPY AGENT GREEN KIT contains indocyanine green (ICG), a tricarbocyanine dye that binds to plasma proteins, primarily albumin, and remains intravascular. It is used for fluorescence imaging to visualize blood vessels, lymphatic structures, and tissues during surgery. ICG fluoresces near-infrared light (NIR) upon excitation, allowing real-time visualization of perfusion and drainage patterns.
CYTALUX (pafolacianine) is administered intravenously at a dose of 0.025 mg/kg (based on actual body weight) over 60 minutes (±10 minutes) once between 1 to 9 hours prior to surgery.
Indocyanine Green 0.25-0.5 mg/kg intravenous bolus as a single dose for cardiac output determination or hepatic function assessment. Repeat dosing after 30-60 minutes if needed.
None Documented
None Documented
Terminal elimination half-life is approximately 3.0 hours. This short half-life supports its use as a photodynamic therapy agent requiring rapid clearance to minimize prolonged photosensitivity.
Terminal elimination half-life is approximately 2.5-3.0 minutes in patients with normal hepatic function; clinically, the rapid clearance allows for repeated assessments of hepatic function and cardiac output.
Renal excretion of unchanged drug accounts for approximately 27% of the administered dose. Fecal excretion (primarily via biliary elimination) accounts for about 43%.
Primarily renal excretion of the intact indocyanine green (ICG) molecule; >90% of the administered dose is cleared unchanged into bile and eliminated in feces, with negligible renal excretion (<5%).
Category C
Category C
Diagnostic Imaging Agent
Diagnostic Imaging Agent